Molecular Detection said today that it has raised $1.4 million as a follow-on to a $3.3 million Series C financing round announced in late 2009.

Molecular Diagnostics, or MDI, said it will use the funding to further develop its pipeline of qualitative real-time PCR in vitro diagnostic tests for infectious diseases.

MentorTech Ventures II led the follow-on financing, which also included Robin Hood Ventures, Elm Spring Holdings, and the Mid-Atlantic Angel Group Fund I and II, all of which are previous investors in MDI.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.